Skip to main content
Veterinary Medicines

Coxi Plus 1000 mg Poeder voor gebruik in drinkwater

Authorised
  • Sulfadimethoxine sodium

Product identification

Medicine name:
Coxi Plus 1000 mg Poeder voor gebruik in drinkwater
Coxi Plus 1000 mg Poudre pour administration dans l’eau de boisson
Coxi Plus 1000 mg Pulver zum Eingeben über das Trinkwasser
Active substance:
  • Sulfadimethoxine sodium
Target species:
  • Pigeon
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • Sulfadimethoxine sodium
    1000.00
    milligram(s)
    /
    4.00
    gram(s)
Pharmaceutical form:
  • Powder for use in drinking water
Withdrawal period by route of administration:
  • In drinking water use
    • Pigeon
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP51AG02
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • Coxi Plus 1000 mg Powder for use in drinking water Box with 8 sachets with 1 gram of Sulfadimethoxine sodium

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Oropharma
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lelypharma B.V.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V149956
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 21/02/2024
French (PDF)
Published on: 21/02/2024
German (PDF)
Published on: 21/02/2024

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 21/02/2024
French (PDF)
Published on: 21/02/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 21/02/2024
French (PDF)
Published on: 21/02/2024
German (PDF)
Published on: 21/02/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."